Phase 4 Human Immunodeficiency Virus (HIV) Clinical Trials
3 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–3 of 3 trials
Recruiting
Phase 4
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
Smoking CessationHuman Immunodeficiency Virus (HIV)
New York University500 enrolled1 locationNCT06598397
Active
Phase 4
A randomised open-label study comparing the safety and efficacy of ritonavir boosted lopinavir and 2-3 nucleoside reverse transcriptase inhibitors (NRTI) backbone versus ritonavir boosted lopinavir and raltegravir in participants virologically failing first-line non-nucleoside reverse transcriptase inhibitors (NNRTI)/2 NRTI therapy (the SECOND-LINE study). This study is for Human Immunodeficiency Virus (HIV) infection.
Human Immunodeficiency Virus (HIV) -1 infection
University of New South Wales/Kirby Institute550 enrolled31 locationsACTRN12609000881235
Completed
Phase 4
Cardiovascular function with switching from Kivexa to Truvada (or from Abacavir to Tenofovir).
Human Immunodeficiency Virus (HIV)Cardiovascular function
St Vincents Hospital20 enrolled1 locationACTRN12609000014257